STAASTAAR Surgical Company

$860M

Q2 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$99M+7.3% YoY

Gross Profit

$78M79.2% margin

Operating Income

$12M12.0% margin

Net Income

$7M7.5% margin

EPS (Diluted)

$0.15

QoQ Revenue Growth

+28.0%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$17M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$513M

Total Liabilities

$104M

Stockholders' Equity

$409M

Cash & Equivalents

$193M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$99M	$92M	+7.3%
Gross Profit	$78M	$71M	+10.9%
Operating Income	$12M	$9M	+38.4%
Net Income	$7M	$6M	+21.7%

Revenue Segments

Implantable Collamer Lenses

$99M100%

STAA Q2 2024 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena